Skip to main content
. 2023 May 16;5(4):504–517. doi: 10.1016/j.jaccao.2023.03.013

Figure 2.

Figure 2

Figure 2

Figure 2

CHD Incidence in BMT Survivors With and Without CVRFs

CVRFs included diabetes, hypertension, and dyslipidemia. (A) CHD incidence in alive BMT survivors by CVRFs. Cumulative incidence of CHD is shown in alive BMT survivors with (blue) and without (orange) CVRFs at BMT. (B) CHD incidence by CVRFs in alive allogeneic BMT survivors. The cumulative incidence of CHD is shown in alive allogeneic BMT survivors with (blue) and without (orange) CVRFs at BMT. (C) CHD incidence by CVRFs in alive autologous BMT survivors. The cumulative incidence of CHD is shown in alive autologous BMT survivors with (blue) and without (orange) CVRFs at BMT. Abbreviations as in Figure 1.